HL
Healios K.K.
HLOSF · OTC
$2.70 +50.00% (+$0.90)
Market Cap ¥37.9B
P/E Ratio 204.88x
Div. Yield -
ROE 3.06%
Piotroski F-Score Moderate
4/9Valuation
12 /100
Expensive P/S 639.98x
P/B 4.36x
P/E 204.88x
Growth
45 /100
Stable Book val. growth 3.75%
Rev. growth 4.97%
FCF growth N/A
Profitability
20 /100
Weak Net margin 312.37%
Op. margin 7,091.59%
FCF margin 7,414.54%
Quality
5 /100
Poor ROE 3.06%
ROA 0.81%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 2.37x
Int. coverage -1.07x
Debt/Equity 0.29x
Stability
36 /100
Moderate Rev. volatility 230.43%
EPS volatility 21.30%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre HLOSF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Tadahisa S. Kagimoto
Employees
75
Headquarters
Tokyo
Evenimente viitoare
18 NOV.
Earnings
Upcoming earnings report